Trevi Therapeutics, Inc.
TRVI
$16.64
-$0.18-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.80M | -13.19M | -8.32M | -11.80M | -12.30M |
| Total Depreciation and Amortization | 34.00K | 34.00K | 31.00K | 38.00K | 38.00K |
| Total Amortization of Deferred Charges | -- | -- | 26.00K | -- | -- |
| Total Other Non-Cash Items | 2.86M | 1.87M | 902.00K | 1.05M | 1.11M |
| Change in Net Operating Assets | -2.52M | -5.40M | -274.00K | -169.00K | 1.05M |
| Cash from Operations | -17.43M | -16.69M | -7.63M | -10.88M | -10.10M |
| Capital Expenditure | -124.00K | -102.00K | 0.00 | -12.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -111.91M | 17.07M | -30.61M | -50.93M | -2.61M |
| Cash from Investing | -112.04M | 16.97M | -30.61M | -50.94M | -2.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 164.80M | 222.00K | 284.00K | 1.12M | 110.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -445.00K | -- | 0.00 | 506.00K | -368.00K |
| Cash from Financing | 164.36M | 222.00K | 284.00K | 1.63M | 110.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.89M | 498.00K | -37.96M | -60.19M | 97.68M |